Canada markets closed

Iovance Biotherapeutics, Inc. (2LB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
10.38-1.98 (-15.99%)
At close: 05:11PM CEST
Currency in EUR
Earnings EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
No. of Analysts14141414
Avg. Estimate-0.53-0.53-2.1-2.25
Low Estimate-0.58-0.65-2.28-2.54
High Estimate-0.48-0.44-1.98-1.87
Year Ago EPS-0.4-0.47-1.88-2.1
Revenue EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
No. of Analysts13131313
Avg. EstimateN/AN/AN/A3.31M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A21.8M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History2020-09-302020-12-312021-03-312021-06-30
EPS Est.-0.46-0.44-0.49-0.51
EPS Actual-0.4-0.47-0.51-0.53
Difference0.06-0.03-0.02-0.02
Surprise %13.00%-6.80%-4.10%-3.90%
EPS TrendCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.53-0.53-2.1-2.25
7 Days Ago-0.53-0.53-2.1-2.26
30 Days Ago-0.53-0.53-2.1-2.26
60 Days Ago-0.52-0.53-2.08-2.26
90 Days Ago-0.52-0.53-2.08-2.26
EPS RevisionsCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/A11
Up Last 30 DaysN/AN/A11
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth Estimates2LB.FIndustrySector(s)S&P 500
Current Qtr.-32.50%N/AN/AN/A
Next Qtr.-12.80%N/AN/AN/A
Current Year-11.70%N/AN/AN/A
Next Year-7.10%N/AN/AN/A
Next 5 Years (per annum)-19.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A